These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26137111)

  • 21. NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.
    Avci NG; Ebrahimzadeh-Pustchi S; Akay YM; Esquenazi Y; Tandon N; Zhu JJ; Akay M
    Sci Rep; 2020 Aug; 10(1):13352. PubMed ID: 32770097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrrolidine dithiocarbamate sensitizes U251 brain glioma cells to temozolomide via downregulation of
    Tang JH; Huang GH; Mou KJ; Zhang EE; Li N; Du L; Zhu XP; Chen L; Yang H; Zhang KB; Lv SQ
    Oncol Lett; 2017 Nov; 14(5):5135-5144. PubMed ID: 29098021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CAT
    Ji M; Wang L; Chen J; Xue N; Wang C; Lai F; Wang R; Yu S; Jin J; Chen X
    Onco Targets Ther; 2018; 11():3671-3684. PubMed ID: 29983575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cells.
    Lee ES; Ko KK; Joe YA; Kang SG; Hong YK
    Oncol Lett; 2011 Jan; 2(1):115-121. PubMed ID: 22870139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity.
    Remington M; Chtchetinin J; Ancheta K; Nghiemphu PL; Cloughesy T; Lai A
    Neuro Oncol; 2009 Feb; 11(1):22-32. PubMed ID: 18812520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of O6-Substituted Guanine Analogs on O6-methylguanine DNA-methyltransferase Expression and Glioblastoma Cells Viability.
    St-Coeur PD; Cormier M; LeBlanc VC; Morin PJ; Touaibia M
    Med Chem; 2016; 13(1):28-39. PubMed ID: 27396904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression.
    Zhu Z; Du S; Ding F; Guo S; Ying G; Yan Z
    Am J Transl Res; 2016; 8(7):3299-308. PubMed ID: 27508051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide.
    Ciechomska IA; Marciniak MP; Jackl J; Kaminska B
    Front Pharmacol; 2018; 9():1271. PubMed ID: 30450051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance.
    Ma J; Murphy M; O'Dwyer PJ; Berman E; Reed K; Gallo JM
    Biochem Pharmacol; 2002 Apr; 63(7):1219-28. PubMed ID: 11960598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling.
    Duan S; Li M; Wang Z; Wang L; Liu Y
    Onco Targets Ther; 2018; 11():6395-6404. PubMed ID: 30323617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
    Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
    Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis.
    Stillger MN; Chen CY; Lai ZW; Li M; Schäfer A; Pagenstecher A; Nimsky C; Bartsch JW; Schilling O
    Cancer Cell Int; 2023 Mar; 23(1):49. PubMed ID: 36932402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma.
    Wang K; Chen D; Qian Z; Cui D; Gao L; Lou M
    Cancer Cell Int; 2017; 17():117. PubMed ID: 29225516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma.
    Wu Y; Zhang K; Wang H; Chen G; Liu Y; Li W; Zhou Y
    Biochem Biophys Rep; 2022 Dec; 32():101386. PubMed ID: 36407484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.
    Yang B; Ma YB; Chu SH
    Cancer Gene Ther; 2018 Dec; 25(11-12):309-316. PubMed ID: 30140041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
    Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M
    J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular cholesterol level regulates sensitivity of glioblastoma cells against temozolomide-induced cell death by modulation of caspase-8 activation via death receptor 5-accumulation and activation in the plasma membrane lipid raft.
    Yamamoto Y; Tomiyama A; Sasaki N; Yamaguchi H; Shirakihara T; Nakashima K; Kumagai K; Takeuchi S; Toyooka T; Otani N; Wada K; Narita Y; Ichimura K; Sakai R; Namba H; Mori K
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1292-1299. PubMed ID: 29162448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
    Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
    J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N3-substituted temozolomide analogs overcome methylguanine-DNA methyltransferase and mismatch repair precipitating apoptotic and autophagic cancer cell death.
    Zhang J; Hummersone M; Matthews CS; Stevens MF; Bradshaw TD
    Oncology; 2015; 88(1):28-48. PubMed ID: 25277441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.